Specialist, CAR-T Site Logistics & Transportation at Bristol-Myers Squibb

Summit, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

SME knowledge of transportation-related requirements including Hazardous materials, DOT and IATA regulations, Foreign Trade Zone, and US Customs guidelines
Current SME knowledge of the CAR-T Supply Chain and temperature controls for specialty shipping (CRT, 2-8°C, -20°C, liquid nitrogen)
Ability to work Monday-Friday, Hybrid Onsite Day Shift, 9 a.m. - 5 p.m

Responsibilities

Provide daily scheduling and coordination of shipments and domestic transfers, including tracking, delivery confirmations, inter-site transportation, carrier selection, bill of lading (BOL), and cryopreserved materials inbound/outbound activities
Provide SME knowledge to internal stakeholders on transportation-related requirements
Manage and maintain files of inbound and outbound documentation in audit-ready state and coordinate responses to audits or information requests
Generate and maintain LN2 metrics to monitor capacity and present enabling strategy activities to management
Initiate, coordinate, and monitor completion of LN2 capacity enabling activities per SOPs and work instructions
Revise SOPs, WPs, and other documentation to keep Material Logistics and Transportation processes audit-ready and compliant with policies and regulations
Develop and optimize Material Logistics and Transportation processes
Support transportation needs in alignment with global and site policies and procedures
Develop and monitor carrier network to ensure low shipment failures and high performance visibility

Skills

Supply Chain

Logistics

Transportation

CAR-T

cGMP

Cell Therapy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free